These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7975417)

  • 1. [Hypolipidemic action of phospholipid compounds in experimental animals].
    Okunevich IV; Ryzhenkov VE; Ulesov AV; Makarevich IF; Mokrouz MV; Davigora IV
    Vopr Pitan; 1994; (3):19-21. PubMed ID: 7975417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The hypolipidemic activity of natural substances].
    Okunevich IV; Kliueva NN; Solov'eva MA; Triufanov VF; Ryzhenkov VE
    Eksp Klin Farmakol; 1992; 55(5):44-7. PubMed ID: 1305452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypolipidemic properties of triterpenoids].
    Vasilenko IuK; Lisevitskaia LI; Frolova LM; Parfent'eva EP; Skul'te IV
    Farmakol Toksikol; 1982; 45(5):66-70. PubMed ID: 7140959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of substances with antihypoxic action in experimental hyperlipidemia].
    Ryzhenkov VE; Remezova OV; Triufanov VF; Vasil'eva LE
    Eksp Klin Farmakol; 1992; 55(5):39-41. PubMed ID: 1305449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
    Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of non-starch polysaccharide crylan in experimental hyperlipidemia].
    Remezova OV; Okunevich IV; Vitovskaia GA; Anan'eva EP; Ryzhenkov VE
    Vopr Pitan; 1995; (2):14-6. PubMed ID: 7483461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
    Ryzhenkov VE; Chistiakova AM; Okunevich IV
    Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic effect of Coriandrum sativum L. in triton-induced hyperlipidemic rats.
    Lal AA; Kumar T; Murthy PB; Pillai KS
    Indian J Exp Biol; 2004 Sep; 42(9):909-12. PubMed ID: 15462185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypolipidemic effects of alisat and lipostabil in patients with diabetes mellitus].
    Mel'chinskaia EN; Gromnatskiĭ NI; Kirichenko LL
    Ter Arkh; 2000; 72(8):57-8. PubMed ID: 11019431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures.
    Seri K; Matsuo T; Taniguchi T; Amemiya K; Kudo M; Saito G; Kato T
    Arzneimittelforschung; 1980; 30(10):1694-703. PubMed ID: 7192109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of hypolipidemic effects of omega-3 polyunsaturated acids and lipostabil].
    Pogozheva AV; Bobkova SN; Samsonov MA; Vasil'ev AV
    Vopr Pitan; 1996; (4):31-3. PubMed ID: 8984798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P; Kaviarasan K; Pugalendi KV
    Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Essentiale on the blood lipid indicators in progressive Duchenne muscular dystrophy].
    Islamova IB; Grinio LP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):83-5. PubMed ID: 2800822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different quantities of fat on serum and liver lipids, phospholipid class distribution and fatty acid composition in alcohol-treated rats.
    Ristić-Medić D; Ristić G; Tepsić V; Ristić GN
    J Nutr Sci Vitaminol (Tokyo); 2003 Dec; 49(6):367-74. PubMed ID: 14974725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gamichunggantang on hyperlipidemia.
    Son CG; Choi WJ; Shin JW; Han SH; Cho JH; Song KC; Cho CK
    Acta Pharmacol Sin; 2003 Feb; 24(2):133-9. PubMed ID: 12546720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypolipidemic action of beta-D-glycoside beta-sitosterol in the rat].
    Mironova VN; Kalashnikova LA
    Farmakol Toksikol; 1982; 45(6):45-7. PubMed ID: 7151999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
    Högberg T; Bondesson G; Misiorny A; Stjernström NE
    Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipostabil forte in the control of hyperlipidemia in diabetics].
    Tomasević M; Zulić S
    Med Arh; 1984; 38(6):279-82. PubMed ID: 6400977
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of L-DOPA on the development of experimental hyperlipidemia and atherosclerosis].
    Mosina IV; Ryzhenkov VE
    Biull Eksp Biol Med; 1981 Mar; 91(3):270-1. PubMed ID: 7248493
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical effects of garlic protein on lipid metabolism in alcohol fed rats.
    Rajasree CR; Rajamohan T; Augusti KT
    Indian J Exp Biol; 1999 Mar; 37(3):243-7. PubMed ID: 10641153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.